enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Monoclonal antibody - Wikipedia

   en.wikipedia.org/wiki/Monoclonal_antibody

   A monoclonal antibody (mAb, more rarely called moAb) is an antibody produced from a cell lineage made by cloning a unique white blood cell. All subsequent antibodies derived this way trace back to a unique parent cell.

3. Monoclonal antibody therapy - Wikipedia

   en.wikipedia.org/wiki/Monoclonal_antibody_therapy

   The advantage of active monoclonal antibody therapy is the fact that the immune system will produce antibodies long-term, with only a short-term drug administration to induce this response. However, the immune response to certain antigens may be inadequate, especially in the elderly.

4. Abelacimab - Wikipedia

   en.wikipedia.org/wiki/Abelacimab

   Download QR code; Print/export Download as PDF; Printable version; In other projects ... is a fully human monoclonal antibody for the treatment of coagulation, [1] ...

5. List of therapeutic monoclonal antibodies - Wikipedia

   en.wikipedia.org/wiki/List_of_therapeutic...

   This list of over 500 monoclonal antibodies includes approved and investigational drugs as well as drugs that have been withdrawn from market; consequently, the column Use does not necessarily indicate clinical usage. See the list of FDA-approved therapeutic monoclonal antibodies in the monoclonal antibody therapy page.

6. Frexalimab - Wikipedia

   en.wikipedia.org/wiki/Frexalimab

   Download as PDF; Printable version; In other projects Wikidata item; ... Frexalimab (SAR441344) is a second-generation monoclonal antibody that inhibits CD40 ligand.

7. Monalizumab - Wikipedia

   en.wikipedia.org/wiki/Monalizumab

   Download as PDF; Printable version; In other projects Wikidata item; ... Monalizumab is a monoclonal antibody targeted at NKG2A. [4] It is a checkpoint inhibitor. [5] [6]

8. Lirilumab - Wikipedia

   en.wikipedia.org/wiki/Lirilumab

   Download as PDF; Printable version; In other projects Wikidata item; ... Lirilumab is a human monoclonal antibody designed for the treatment of cancer. [1] [2] ...

9. Sugemalimab - Wikipedia

   en.wikipedia.org/wiki/Sugemalimab

   Sugemalimab, sold under the brand name Cejemly among others, is a monoclonal antibody used for the treatment of metastatic non-small cell lung cancer (NSCLC) in combination with chemotherapy. [1] It is an antineoplastic monoclonal antibody that potentiates T-cell responses, including anti-tumor responses, through blockade of PD-1 binding to PD ...